These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10547593)

  • 21. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
    Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
    Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer.
    Müller W; Schneiders A; Heider KH; Meier S; Hommel G; Gabbert HE
    J Pathol; 1997 Oct; 183(2):222-7. PubMed ID: 9390037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant correlations of E-cadherin, catenin, and CD44 variant form expression with carcinoma cell differentiation and prognosis of extrahepatic bile duct carcinomas.
    Mikami T; Saegusa M; Mitomi H; Yanagisawa N; Ichinoe M; Okayasu I
    Am J Clin Pathol; 2001 Sep; 116(3):369-76. PubMed ID: 11554165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours.
    Munchar MJ; Sharifah NA; Jamal R; Looi LM
    Pathology; 2003 Apr; 35(2):125-9. PubMed ID: 12745459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 is expressed in hepatocellular carcinomas showing vascular invasion.
    Mathew J; Hines JE; Obafunwa JO; Burr AW; Toole K; Burt AD
    J Pathol; 1996 May; 179(1):74-9. PubMed ID: 8691349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44s expression, in benign, borderline and malignant tumors of ovarian surface epithelium. Correlation with p53, steroid receptor status, proliferative indices (PCNA, MIB1) and survival.
    Zagorianakou N; Stefanou D; Makrydimas G; Zagorianakou P; Briasoulis E; Karavasilis B; Agnantis NJ
    Anticancer Res; 2004; 24(3a):1665-70. PubMed ID: 15274338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
    Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
    Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD44s and CD44 splice variants in human melanoma.
    Ranuncolo SM; Ladeda V; Gorostidy S; Morandi A; Varela M; Lastiri J; Loria D; Del Aguila R; Joffé EB; Pallotta G; Puricelli L
    Oncol Rep; 2002; 9(1):51-6. PubMed ID: 11748454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
    Brustmann H
    Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tokuda M
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H
    Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours.
    Saegusa M; Hashimura M; Machida D; Okayasu I
    J Pathol; 1999 Jan; 187(2):173-83. PubMed ID: 10365092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
    Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
    Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.